A Phase I Clinical Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Preliminary Pharmacodynamics of HLX22Monoclonal Antibody Injection in Patients with Advanced Solid Tumours Overexpressing HER2
Title | A Phase I Clinical Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Preliminary Pharmacodynamics of HLX22Monoclonal Antibody Injection in Patients with Advanced Solid Tumours Overexpressing HER2 |
---|---|
Description | To evaluate the safety and maximum to leated dose (MTD) of HLX 22 in patients with advanced or metastatic solid tumours which are non-responsive to standard therapies,screening 20 patients, enrolment 11 Patients. |
Organism | Homo sapiens |
Data Type | Other Type of Metabolome Data |
Data Accessibility | Controlled-access |
BioProject | PRJCA014975 |
Release Date | 2023-02-16 |
Submitter | Yanhua Ding (18343115092@163.com) |
Organization | The First Hospital of Jilin University |
Submission Date | 2023-02-15 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
---|---|---|---|---|---|---|---|
OMIX002997-01 | HLX22-001HER1data | 11 | Other Type of Metabolome Data | 16.1 KB | xlsx | 0 | Controlled |
OMIX002997-02 | HLX22-001HER2Data | 11 | Other Type of Metabolome Data | 12.4 KB | xlsx | 0 | Controlled |
OMIX002997-03 | HLX22-001PKDATA | 11 | Other Type of Metabolome Data | 21.9 KB | xlsx | 0 | Controlled |
OMIX002997-04 | HLX22-001ADA data | 11 | Other Type of Metabolome Data | 11.4 KB | xlsx | 0 | Controlled |